{
    "Case ID": "077774",
    "Crime_Name": [
        "Patent Infringement"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent validity and infringement"
    ],
    "Legal_Issue": [
        "Whether Pfizer's patent is valid and whether Apotex's process infringes the patent claims"
    ],
    "Governing_Law": [
        "Patented Medicines (Notice of Compliance) Regulations",
        "Patent Act"
    ],
    "Procedural_Stage": [
        "Judicial review of regulatory approval application"
    ],
    "Evidence_Assessment": [
        "Expert testimonies, prior art, chemical equivalence analysis"
    ],
    "Decision_Outcome": [
        "Pfizer's patent is valid; Apotex's process infringes the patent"
    ],
    "Burden_of_Proof": [
        "On Apotex to prove patent invalidity"
    ],
    "Credibility_Factor": [
        "Expert testimony on chemical properties and processes"
    ],
    "Legal_Rule": [
        "A patent is presumed valid unless proven otherwise; infringement occurs if a process uses obvious chemical equivalents"
    ],
    "Standard_of_Review": [
        "Balance of probabilities"
    ],
    "Procedural_Issue": [
        "Regulatory approval under NOC Regulations"
    ],
    "Grounds_for_Claim": [
        "Apotex alleged non-infringement and patent invalidity based on prior art"
    ],
    "Outcome_on_Merits": [
        "In favor of Pfizer"
    ],
    "Decision_Maker": [
        "Court"
    ],
    "Judicial_Review_Outcome": [
        "Prohibition order granted"
    ],
    "Review_Standard": [
        "Statutory interpretation and factual assessment under Patent Act"
    ],
    "Procedural_Fairness_Assessment": [
        "Full hearing with opportunity to present evidence"
    ],
    "Key_Evidence_Considered": [
        "Prior patents, unexpected properties of fluconazole, ACIC Pathway vs. patented process"
    ],
    "Legal_Framework": [
        "Patent Act and NOC Regulations"
    ],
    "Applicant_Challenge": [
        "Apotex challenged patent validity and claimed non-infringement"
    ],
    "Court_Result": [
        "Prohibition order issued"
    ],
    "Legal_Rule_Source": [
        "Patent Act, Canadian case law"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Denial of infringement and challenge to patent validity"
    ],
    "Evidence_Type": [
        "Documentary evidence, expert scientific testimony"
    ],
    "Remedy_Requested": [
        "Prevention of regulatory approval for generic drug"
    ],
    "Outcome": [
        "Prohibition order granted; Apotex barred until patent expiry"
    ],
    "Decision_Authority": [
        "Federal Court"
    ],
    "Remedy_Sought": [
        "Interim injunction preventing marketing approval"
    ],
    "Resolution_Mechanism": [
        "Judicial determination"
    ],
    "Legal_Provision": [
        "Section 6 of the Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Authority": [
        "Canadian Federal Court"
    ],
    "Claimant_Status": [
        "Patent holder (Pfizer)"
    ],
    "Legal_Provision_Cited": [
        "Patent Act, R.S.C. 1985, c. P-4",
        "NOC Regulations"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Prior art, lack of novelty, non-infringement"
    ],
    "Applicable_Process": [
        "Notice of Compliance proceeding"
    ],
    "Outcome_of_Review": [
        "Appeal dismissed; prohibition upheld"
    ],
    "Pending_Relief_or_Application": [
        "Regulatory approval for generic fluconazole"
    ],
    "Jurisdiction": [
        "Canada"
    ],
    "Governing_Rule": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ]
}